These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2700533)

  • 1. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
    Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
    Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
    Linkesch W; Ludwig H
    Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognosis of patients with multiple myeloma--the aspect of histological distribution to the renal tissue and serum level of beta 2-MG].
    Inoue Y; Suzuki K; Enomoto H; Takemura T; Nakamura K
    Rinsho Ketsueki; 1992 Aug; 33(8):1012-6. PubMed ID: 1404855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of lactate dehydrogenase and beta 2-microglobulin levels for the assessment of the prognosis and choice of therapy in multiple myeloma].
    Iakovleva SV; Andreeva NE; Izgorodin AS
    Ter Arkh; 1995; 67(7):35-9. PubMed ID: 7482303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta2-Microglobulin and monoclonal gammapathies (author's transl)].
    Belleville F; Bertrand F; Nabet P
    Pathol Biol (Paris); 1978 Sep; 26(6):348-50. PubMed ID: 83581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma.
    Musolino C; Allegra A; Orlando A; Grosso P; Alonci A; Cincotta M; Squadrito G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):233-8. PubMed ID: 2103961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta 2 microglobulin in some hematologic neoplasms].
    Rodríguez MA; Lira P; Foradori A; Grebe G
    Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between clinical stage of sarcoidosis and serum values of angiotensin converting enzyme and beta2-microglobulin.
    Selroos O; Klockars M
    Sarcoidosis; 1987 Mar; 4(1):13-7. PubMed ID: 3035674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment serum beta 2-microglobulin in multiple myeloma.
    Brenning G; Simonsson B; Källander C; Ahre A
    Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple myeloma with 5-year survival. Study of initial prognostic factors. Role of beta-2-microglobulin].
    Franco M; Fuzibet JG; Cassuto JP; Pesce A; Ziegler G; Dujardin P
    Rev Rhum Mal Osteoartic; 1985 Nov; 52(11):619-23. PubMed ID: 3909365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
    Bataille R; Grenier J; Sany J
    Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.